483 Progenics Pharmaceuticals Sep 2017

483 Progenics Pharmaceuticals Sep 2017

$119 - Not in Stock

FDA investigators audited the Progenics Pharmaceuticals - New York, NY, United States facility and issued inspectional observations (via FDA 483) on 11 Sep 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 11 Sep 2017
  • Location: New York, United States
  • FEI: 3013080312
Order